<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Greub G</dc:creator>
  <dc:creator>Frei PC</dc:creator>
  <dc:date>2001</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">BACKGROUND/AIMS
The 'anti-Hbc alone' pattern could sometimes be that of subjects who produced anti-HBs after recovery, but at a lower level than that detectable using commercial assays. This study aimed to test this hypothesis.


METHODS
A total of 104 'anti-HBc alone' serum samples, i.e.positive for the anti-HBc antibody but not for HBsAg nor for anti-HBs antibody, were recruited when routine testing a broad population of employees, patients and pregnant women from a university hospital. A possible subliminal anti-HBs production, that would have escaped detection by commercial EIAs, was investigated by comparing the optical densities (ODs) obtained in vaccinees (commercial anti-HBs EIA) to those of a control group of 100 nonimmunised and nonvaccinated subjects.


RESULTS
The median OD was significantly higher (p&lt;0.0001) in the 'anti-HBc alone' subjects (OD=0.035) than in the controls (OD=0.023). Thirty-six percent of the 'anti-HBc alone' subjects had an anti-HBs OD higher than the median OD of the controls+2SD. 'Anti-HBc alone' subjects with anti-HBe antibody had higher anti-HBs ODs (0.041) than had those without anti-HBe (0.029). In 'anti-HBc alone' subjects, the anti-HBs ODs, although under the cut-off value of the EIA, were found to be higher than in the controls.


CONCLUSION
Our results show low anti-HBs production in some of the subjects studied.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/124080</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1034/j.1600-0676.2001.210603.x</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/11903881</dc:relation>
  <dc:source>Liver. - 2001</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Adolescent</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Adult</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Aged</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Epitopes</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Hepatitis B</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Hepatitis B Antibodies</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Hepatitis B Core Antigens</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Hepatitis B Surface Antigens</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Hepatitis B virus</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Immunoenzyme Techniques</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Male</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Middle Aged</dc:subject>
  <dc:title xmlns:ns15="xml" ns15:lang="en">Presence of low levels of anti-HBs antibody in so-called 'anti-HBc alone' subjects.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
